cbdMD (YCBD) Capital Expenditures Growth (5y) (2021 - 2025)
cbdMD (YCBD) Capital Expenditures Growth (5y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | cbdMD | 4.57 Mn | 1.18 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.05% |
| Sep 30, 2025 | 14.93% |
| Jun 30, 2025 | -51.58% |
| Mar 31, 2025 | -58.37% |
| Dec 31, 2024 | -21.62% |
| Sep 30, 2024 | -58.77% |
| Mar 31, 2024 | -15.44% |
| Dec 31, 2023 | 79.44% |
| Sep 30, 2023 | 41.62% |
| Mar 31, 2023 | -248.21% |
| Dec 31, 2022 | 131.55% |
| Sep 30, 2022 | 102.58% |
| Mar 31, 2022 | 78.02% |
| Dec 31, 2021 | 101.04% |